These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 34157386)
21. Whole Inactivated Virus and Protein-Based COVID-19 Vaccines. Hotez PJ; Bottazzi ME Annu Rev Med; 2022 Jan; 73():55-64. PubMed ID: 34637324 [TBL] [Abstract][Full Text] [Related]
22. Cross-country evidence on the role of national governance in boosting COVID-19 vaccination. Aida T; Shoji M BMC Public Health; 2022 Mar; 22(1):576. PubMed ID: 35321676 [TBL] [Abstract][Full Text] [Related]
23. COVID-19 vaccination in the Indian blood donors: Adjudging the impact on the deferral period. Bansal N; Raturi M Transfus Clin Biol; 2021 Aug; 28(3):310-312. PubMed ID: 33857620 [TBL] [Abstract][Full Text] [Related]
24. Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID-19 in the UAE. Ahamed F; Ganesan S; James A; Zaher WA BMC Public Health; 2021 Aug; 21(1):1602. PubMed ID: 34461846 [TBL] [Abstract][Full Text] [Related]
25. Investigating the Links Between Vaccination Against COVID-19 and Public Attitudes Toward Protective Countermeasures: Implications for Public Health. Si R; Yao Y; Zhang X; Lu Q; Aziz N Front Public Health; 2021; 9():702699. PubMed ID: 34368065 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. Jara A; Undurraga EA; González C; Paredes F; Fontecilla T; Jara G; Pizarro A; Acevedo J; Leo K; Leon F; Sans C; Leighton P; Suárez P; García-Escorza H; Araos R N Engl J Med; 2021 Sep; 385(10):875-884. PubMed ID: 34233097 [TBL] [Abstract][Full Text] [Related]
27. COVID-19 vaccines: concerns beyond protective efficacy and safety. Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347 [TBL] [Abstract][Full Text] [Related]
28. INACTIVATED COVID-19 VACCINE CAN INDUCE REACTIVE POLYARTHRITIS IN OLDER PATIENTS: REPORT OF TWO CASES. Türk SM; Öztürk Z; Karataş D; Gönüllü E Georgian Med News; 2021 Oct; (319):100-102. PubMed ID: 34749331 [TBL] [Abstract][Full Text] [Related]
29. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge. He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724 [TBL] [Abstract][Full Text] [Related]
30. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)]. National Immunization Advisory Committee Technical Working Group Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228 [TBL] [Abstract][Full Text] [Related]
31. Bhutan's COVID-19 Vaccination Efforts and the Evolution of COVID-19 Cases in the Aftermath. Gyeltshen D; Dema T; Ahmadi A; Lucero-Prisno DE Asia Pac J Public Health; 2022 Jan; 34(1):125-127. PubMed ID: 34670431 [TBL] [Abstract][Full Text] [Related]
32. People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis. Eibensteiner F; Ritschl V; Nawaz FA; Fazel SS; Tsagkaris C; Kulnik ST; Crutzen R; Klager E; Völkl-Kernstock S; Schaden E; Kletecka-Pulker M; Willschke H; Atanasov AG J Med Internet Res; 2021 Apr; 23(4):e28973. PubMed ID: 33872185 [TBL] [Abstract][Full Text] [Related]
34. [What are the differences between the various covid-19 vaccines?]. Ligtenberg AJM; Brand HS Ned Tijdschr Tandheelkd; 2021 Jul; 128(epub ahead of print 2021):. PubMed ID: 34228411 [TBL] [Abstract][Full Text] [Related]
35. The Effect of Vaccination Rates on the Infection of COVID-19 under the Vaccination Rate below the Herd Immunity Threshold. Chen YT Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299942 [TBL] [Abstract][Full Text] [Related]
37. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China. Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682 [TBL] [Abstract][Full Text] [Related]
38. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 vaccines, where do we stand? Fischer A C R Biol; 2021 Jun; 344(1):43-55. PubMed ID: 34213848 [TBL] [Abstract][Full Text] [Related]
40. COVID-19 vaccination in our transplant recipients: The time is now. Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]